Member Posts > Cardiol Therapeutics to Discuss Groundbreaking Research in Heart Disease at TD Cowen Conference
Cardiol Therapeutics Inc., a biotechnology firm dedicated to advancing therapies for cardiovascular diseases, has announced its upcoming presentation at the TD Cowen 45th Annual Health Care Conference. Taking place in Boston on March 5, 2025, at 11:10 AM EST, the event will offer Cardiol a platform to present its latest findings on anti-inflammatory and anti-fibrotic treatments for heart disease.
The company has been proactive in sharing its progress with the broader medical and investment communities. Earlier this year, on February 11, 2025, Cardiol Therapeutics presented at the Oppenheimer 35th Annual Healthcare Life Sciences Conference, providing updates on its clinical trials and research initiatives. Furthermore, on September 26, 2023, CEO David Elsley spoke at the Cantor Fitzgerald 2023 Global Healthcare Conference, outlining the company's vision for transforming cardiovascular treatment.
Cardiol Therapeutics' ongoing participation in these events reinforces its commitment to driving medical innovation and enhancing patient care through groundbreaking therapies for heart disease.

#CardiolTherapeutics #HeartHealth #BiotechInvestments #MedicalResearch #CardiovascularMedicine #HealthcareInnovation